Other Species / Isoforms
  TGFB1 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K42-ub
TIDMELVkRKRIEAI
0 1
TGFB1 (human) TIDMELVkRKRIEAI K42-ub
TGFB1 (mouse) TIDMELVKRKRIEAI K42
TGFB1 (rat) TIDMELVKRKRIEAI K42
K42-sm
TIDMELVkRKRIEAI
0 1
TGFB1 (human) TIDMELVkRKRIEAI K42-sm
TGFB1 (mouse) TIDMELVKRKRIEAI K42
TGFB1 (rat) TIDMELVKRKRIEAI K42
N82
EAVLALYNSTRDRVA
0 1
TGFB1 (human) EAVLALYNSTRDRVA N82
TGFB1 (mouse) EAVLALYnSTRDRVA N82-ng
TGFB1 (rat) EAVLALYNSTRDRVA N82
K106-ub
PEADYYAkEVTRVLM
0 3
TGFB1 (human) PEADYYAkEVTRVLM K106-ub
TGFB1 (mouse) PEADYYAKEVTRVLM K106
TGFB1 (rat) PEADYYAKEVTRVLM K106
K163-ub
RLLRLKLkVEQHVEL
0 2
TGFB1 (human) RLLRLKLkVEQHVEL K163-ub
TGFB1 (mouse) RLQRLKSSVEQHVEL S163
TGFB1 (rat) RLQRFKSTVEQHVEL T163
K291-ub
YCFSSTEkNCCVRQL
0 3
TGFB1 (human) YCFSSTEkNCCVRQL K291-ub
TGFB1 (mouse) YCFSSTEKNCCVRQL K291
TGFB1 (rat) YCFSSTEKNCCVRQL K291
K315-ub
WKWIHEPkGyHANFC
Upstream
Downstream
1 1
Effects on Modified Protein
  • protein degradation
Treatment
  • ursodeoxycholic_acid
TGFB1 (human) WKWIHEPkGyHANFC K315-ub
TGFB1 (mouse) WKWIHEPKGYHANFC K315
TGFB1 (rat) WKWIHEPKGYHANFC K315
Y317-p
WIHEPkGyHANFCLG
0 1
TGFB1 (human) WIHEPkGyHANFCLG Y317-p
TGFB1 (mouse) WIHEPKGYHANFCLG Y317
TGFB1 (rat) WIHEPKGYHANFCLG Y317